Developments in high-throughput microbial genomic sequencing and other systems biology
techniques have given novel insight into the potential contribution of the gut microbiota to …

Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Faecal microbiota transplantation (FMT) is a promising therapy for chronic diseases
associated with gut microbiota alterations. FMT cures 90% of recurrent Clostridioides difficile …

Background Increasing evidence supports the role of the gut microbiota in the aetiology of
irritable bowel syndrome (IBS). Faecal microbiota transplantation (FMT) is a highly effective …

The human body is home to a variety of micro-organisms. Most of these microbial
communities reside in the gut and are referred to as gut microbiota. Over the last decades …

Fecal microbiota transplantation (FMT) is highly effective in preventing recurrent
Clostridioides difficile infection (rCDI). However, the mechanisms underpinning its clinical …

Intestinal proteases mediate digestion and immune signalling, while increased gut
proteolytic activity disrupts the intestinal barrier and generates visceral hypersensitivity …

Fecal microbiota transplantation (FMT) has been used as a core therapy for treating
dysbiosis-related diseases by remodeling gut microbiota. The methodology and technology …

Background Randomized controlled trials (RCTs) have examined the efficacy of fecal
microbiota transplantation (FMT) in irritable bowel syndrome (IBS) with inconsistent results …

Background Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis.
Aim To investigate the efficacy of faecal microbiota transplantation (FMT) in the treatment of …